Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Condyline 0.5% solution
1307000K0BCAAAA
|
Condyline | Podophyllotoxin | Skin | 32 |
|
Delph sun lotion SPF 30
130801000BBKZA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 32 |
|
Generic Capasal Therapeutic shampoo
1309000C0AAAQAQ
|
Coal tar (Scalp) | Coal tar | Skin | 32 |
|
White soft paraffin 10% spray
1302010N0AAACAC
|
Paraffin Soft white | Paraffin soft white | Skin | 32 |
|
Anthisan Bite and Sting 2% cream
1303000M0BBABAA
|
Anthisan (Topical) | Mepyramine maleate | Skin | 31 |
|
Lipikar Baume AP+ Lipid-Replenishing balm
131500000BBNCA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 31 |
|
Salicylic acid 10% in Aqueous cream
1305020S0AACRCR
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 31 |
|
Ultrasun Extreme lotion SPF 50+
130801000BBPEA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 31 |
|
Benzocaine 3% cream
1303000B0AAAFAF
|
Benzocaine (Topical) | Benzocaine | Skin | 30 |
|
Chlorhexidine glucon 2%/Isopropyl alcohol 70% soln 1.5ml
1311020L0AABXBX
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 30 |
|
Daktarin Intensiv 2% cream
1310020L0BCABAA
|
Daktarin (Ketoconazole) | Ketoconazole | Skin | 30 |
|
Derma Shield skin protector mousse
130202000BBBAA0
|
Proprietary compound preparation BNF 1302020 | Other barrier preparations | Skin | 30 |
|
Gamolen 80mg capsules
1305010I0BVABAB
|
Gamolen | Gamolenic acid | Skin | 29 |
|
Sunsense sunsensitive cream SPF 50+
130801000BBNVA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 29 |
|
Chloroxylenol 4.8% solution
1311050E0AAACAC
|
Chloroxylenol | Chloroxylenol | Skin | 28 |
|
Nerisone Forte 0.3% ointment
1304000L0BBAEBC
|
Nerisone | Diflucortolone valerate | Skin | 28 |
|
Hedrin 4% spray
1310040V0BBAEAE
|
Hedrin | Dimeticone (Parasiticidal) | Skin | 27 |
|
ClobaDerm 0.05% cream (Auden McKenzie)
1304000G0BFAAAA
|
ClobaDerm | Clobetasol propionate | Skin | 26 |
|
Coal tar 5% ointment in a base
1305020C0AAAVAV
|
Coal tar/tar (Topical) | Tars | Skin | 26 |
|
Diphenhydramine 2% cream
1303000J0AAAAAA
|
Diphenhydramine hydrochloride (Topical) | Diphenhydramine hydrochloride | Skin | 26 |
|
Lansinoh Brand Lanolin ointment
1301010W0BBAAAB
|
Lansinoh | Wool fat | Skin | 26 |
|
Camellia sinensis extract 10% ointment
1307000W0AAAAAA
|
Camellia sinensis extract | Camellia sinensis extract | Skin | 24 |
|
Salicylic acid 5% cream
1305020S0AAA4A4
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 24 |
|
Allergenics emollient cream
130201000BBIUA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 23 |
|
Coal tar 10% ointment in a base
1305020C0AABSBS
|
Coal tar/tar (Topical) | Tars | Skin | 23 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.